Poly-Dtech
Created in 2019
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
489 1,452Activities
Technologies
Entity types
Location
204 Av. de Colmar, 67100 Strasbourg, France
Strasbourg
France
Employees
Scale: 2-10
Estimated: 4
SIREN
850615766Engaged corporates
17
7 16Added in Motherbase
4 years, 9 months ago
biotech Value proposition
Enhance your detection
Founded in 2019, Poly-Dtech is a French company, based in Strasbourg, specializing in innovative solutions for biomarker detection through an advanced cutting-edge technology: Bright-DtechTM
🎯 OUR MISSION: We aim to enhance current screening, drug discovery, and early disease diagnosis by advancing biomarker detection in scientific research and medical diagnostics.
Poly-Dtech develops and produces immunoassays and Lateral Flow tests based on high-performance fluorescent nanoparticles with unique features.
🧪 BRIGHT-DTECHTM TECHNOLOGY: Bright-DtechTM represents a cutting-edge lanthanide-based fluorescent nanoparticles, surpassing existing products by significantly improving biomarker detection across diverse sample types and concentration levels, including previously undetected biomarkers.
⁃ User-friendly protocols
⁃ Handling time reduced by half
⁃ Increased sensitivity in lower concentrations
🖇️ LINK-DTECHTM: Link-DtechTM allows the conjugation of your antibodies or proteins with our “Ready to couple” Bright-DtechTM nanoparticles.
💡ASSAY KITS: Based on Bright-DtechTM technology, we offer high-performance assay kits with higher detection sensitivity compared to traditional biomarker assays
⁃ NoW-DtechTM (TR-FRET) Assay Kits: Human IgG, PSA, Trastuzumab (Monkey)
⁃ FLISA-DtechTM (TR-FLISA) Assay Kits: SARS-CoV-2, Trastuzumab (Monkey)
⁃ Multi-DtechTM (Multiplex) Assay Kits: soon, stay tuned 👀
😷 RAPID TESTS: Poly-Dtech is also specializing in Point of Care Testing through Lateral Flow assays, for reliable and rapid results with our reader
- Quantification
- Results in less than 20 minutes
- Easy and quick interpretation data
🧑🏻🔬 CUSTOM ASSAY DEVELOPMENT: We provide development, optimization and validation of your specific assays, ensuring excellent reproducibility results thanks to our experts to save time and money
⁃ TR-FRET/TR-FLISA Assay Development
⁃ Lateral Flow Assay Development
⁃ Multiplex Assay Development
Contact us ➡️ contact@poly-dtech
Marquage biologique, Luminescence, Spectroscopie, Temps de vie, Brillance, Photostabilité, Baisse des seuils de détection, ELISA, Immunoessais, DIV - IVD, Anticorps, qPCR, Cytométrie de flux, Multiplexing, Nanoparticules, Elimination du bruit de fond, and Réduction des coûtsOriginal language
Enhance your detection !
Founded in 2019, Poly-Dtech is a French company, based in Strasbourg, specializing in innovative solutions for biomarker detection through an advanced cutting-edge technology: Bright-DtechTM
🎯 OUR MISSION: We aim to enhance current screening, drug discovery, and early disease diagnosis by advancing biomarker detection in scientific research and medical diagnostics.
Poly-Dtech develops and produces immunoassays and Lateral Flow tests based on high-performance fluorescent nanoparticles with unique features.
🧪 BRIGHT-DTECHTM TECHNOLOGY: Bright-DtechTM represents a cutting-edge lanthanide-based fluorescent nanoparticles, surpassing existing products by significantly improving biomarker detection across diverse sample types and concentration levels, including previously undetected biomarkers.
⁃ User-friendly protocols
⁃ Handling time reduced by half
⁃ Increased sensitivity in lower concentrations
🖇️ LINK-DTECHTM: Link-DtechTM allows the conjugation of your antibodies or proteins with our “Ready to couple” Bright-DtechTM nanoparticles.
💡ASSAY KITS: Based on Bright-DtechTM technology, we offer high-performance assay kits with higher detection sensitivity compared to traditional biomarker assays
⁃ NoW-DtechTM (TR-FRET) Assay Kits: Human IgG, PSA, Trastuzumab (Monkey)
⁃ FLISA-DtechTM (TR-FLISA) Assay Kits: SARS-CoV-2, Trastuzumab (Monkey)
⁃ Multi-DtechTM (Multiplex) Assay Kits: soon, stay tuned 👀
😷 RAPID TESTS: Poly-Dtech is also specializing in Point of Care Testing through Lateral Flow assays, for reliable and rapid results with our reader
- Quantification
- Results in less than 20 minutes
- Easy and quick interpretation data
🧑🏻🔬 CUSTOM ASSAY DEVELOPMENT: We provide development, optimization and validation of your specific assays, ensuring excellent reproducibility results thanks to our experts to save time and money
⁃ TR-FRET/TR-FLISA Assay Development
⁃ Lateral Flow Assay Development
⁃ Multiplex Assay Development
Contact us ➡️ contact@poly-dtech
Home - Poly-Dtech
Unlock biomarker detection with our Bright-Dtech™ fluorescent nanoparticles and immunoassays solutions to improve your tests and results
https://poly-dtech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 WeWork Real Estate | WeWork Real Estate | Other | ||
 WiSEED Crowdfunding, Financial Services | WiSEED Crowdfunding, Financial Services | Other 11 Oct 2024 | | |
 WILCO Software Development | WILCO Software Development | Other 8 Feb 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 25 Jan 2024 | | |
 CCI GRAND EST Chamber of commerce, Government Administration | CCI GRAND EST Chamber of commerce, Government Administration | Other 8 Feb 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 25 Oct 2024 | | |
 Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 20 Nov 2023 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 4 Oct 2023 | | |
 Ville et Eurométropole de Strasbourg National and local authorities, Government Administration, French metropolis | Ville et Eurométropole de Strasbourg National and local authorities, Government Administration, French metropolis | Other 25 Jun 2023 | | |
 Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 26 May 2023 | | |